MARKET

SISI

SISI

Shineco
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.851
+0.031
+1.68%
Opening 11:38 05/23 EDT
OPEN
1.900
PREV CLOSE
1.820
HIGH
1.900
LOW
1.820
VOLUME
14.09K
TURNOVER
19.59K
52 WEEK HIGH
17.19
52 WEEK LOW
1.700
MARKET CAP
20.06M
P/E (TTM)
-0.4378
1D
5D
1M
3M
1Y
5Y
51 Biggest Movers From Thursday
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.
Benzinga · 04/18 09:21
VSTM, ZY and SGLY among mid-day movers
Gainers: MedAvail Holdings (MDVL) +51%. Borqs Technologies (BRQS) +27%. Verastem (VSTM) +26%. Lexaria Bioscience (LEXX) +22%. Splash Beverage Group (SBEV) +18%. HighPeak Energy (HPK) +17%. Cardiol Therapeutics (CRDL) +16%. Airgain
Seekingalpha · 04/14 16:29
Shineco to raise $2.2M through a securities purchase agreement
Shineco (NASDAQ:SISI) entered into a securities purchase agreement during the week for the sale of ~$2.2M of its registered common stock for $2.26/share. The transaction is expected to close on
Seekingalpha · 04/14 13:25
BRIEF-Shineco Reports Entering into Securities Purchase Agreement with Gross Proceeds of $2.2 Mln
reuters.com · 04/14 12:57
Shineco Announces Entering Into A Securities Purchase Agreement With Gross Proceeds Of $2.2M
hineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that it has entered into a
Benzinga · 04/14 12:31
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of US$2.2 Million
BEIJING, April 14, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that it has entered into a securities p...
GlobeNewswire · 04/14 12:30
China's Shineco Strikes Deal to Sell $2.2 Million Shares to Investors
MT Newswires · 04/14 10:55
BRIEF-Shineco Announces Board, Officer Changes
reuters.com · 03/28 13:45
More
No Data
Learn about the latest financial forecast of SISI. Analyze the recent business situations of Shineco through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.34%
Pharmaceuticals & Medical Research
+1.19%
Key Executives
Chairman/Director
Mike Zhao
Chief Executive Officer/Director
Jennifer Zhan
Chief Financial Officer/Director
Sai Wang
Chief Operating Officer/Director
Xiqiao Liu
Independent Director
Yanzeng An
Independent Director
Hu Li
Independent Director
Jin Liu
No Data
No Data
About SISI
Shineco Inc is a holding company. The Company provides health and well-being focused plant-based products by using its subsidiaries' and variable interest entities' vertically and horizontally integrated production, distribution and sales channels. The Company operates through three segments. Luobuma Products segment develops, manufactures and distributes specialized fabrics, textiles and other by-products derived from an indigenous Chinese plant Apocynum Venetum, as well as Luoboma raw materials processing. The Chinese Medicinal Herbal Products segment processes and distributes traditional Chinese medicinal herbal products as well as other pharmaceutical products. The Other Agricultural Products segment plants, processes and distributes green and organic agricultural produce as well as grows and cultivates yew trees.

Webull offers kinds of Shineco Inc stock information, including NASDAQ:SISI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SISI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SISI stock methods without spending real money on the virtual paper trading platform.